With these enhancements in the Chemotherapy Manager, the system offers tooltips that provide detailed and specific information when users hover over different sections of the flowsheet grid, namely drug dosage, adverse event grade, and performance score.
With this advancement in the Chemotherapy Manager, users have the capability to modify the sequence of modules within flowsheet templates, ensuring an arrangement that is in harmony with individual preferences and workflows. This enhancement ensures that any personalized module sequences are integrated and consistently applied to the flowsheet each time the template is chosen for a plan.
With this enhancement in the AJCC Cancer Staging Version 10, when a cancer stage has already been documented with a specific version and cancer type, and there is a need to document another stage against the same diagnosis with a different version, the previously documented stage is automatically marked as inactive. This inactive stage carries an ‘inactive’ tag for clear identification and is preserved in the system logs. This ensures that users can view all previous stages, along with their respective versions, directly from the staging form, providing a comprehensive historical view of the patient’s cancer staging journey.
With this enhancement in the AJCC Cancer Staging Version 08, incorporation of Oncotype DX values in the staging of Breast Cancer and Breast: Ductal Carcinoma in Situ has been leveraged.
With these enhancements in the AJCC Cancer Staging Version 08, the users have the ability to denote Gleason and PSA values as 'X' during the staging of prostate cancer.
With this enhancement in the Chemotherapy Manager, when assessing a patient’s cancer staging, the user finds added options for Testicular and Colorectal Cancers.
With this enhancement in the Chemotherapy Manager, users can calculate billing units for specific drugs based on their National Drug Code (NDC). This ensures accuracy and precision in the billing practice.
With this enhancement in the Chemotherapy Manager, users can set a default flowsheet template which is then automatically selected whenever a plan is generated for a patient. This assists users by eliminating the need to customize different templates for each new plan.
With this enhancement in the Chemotherapy Manager, users are able to predefine the duration displayed on the patient’s flowsheets for both past and future periods. This ensures that the duration appearing on patients’ flowsheets are prepopulated with the corresponding values selected in Settings.
With this enhancement in the Chemotherapy Manager, the flowsheet displays short names for drugs instead of their full form. This ensures better utilization of the available space on flowsheet to provide clarity.
Posted On: Dec 20, 2024
Posted On: Nov 27, 2024
Posted On: Nov 27, 2024
Posted On: Nov 27, 2024
Posted On: Nov 27, 2024
Posted On: Nov 27, 2024